Net Cash Provided by (Used in) Operating Activities |
-39.4K |
USD |
+96.1% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
-707 |
USD |
-101% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
1.13M |
USD |
+443% |
Q1 2024 |
Q1 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
304K |
USD |
|
Q1 2023 |
Q1 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
83.8K |
USD |
-75.3% |
Q2 2025 |
Q2 2025 |
Deferred Tax Assets, Valuation Allowance |
275K |
USD |
+142% |
Q4 2024 |
FY 2024 |
Deferred Tax Assets, Gross |
275K |
USD |
+142% |
Q4 2024 |
FY 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
227K |
USD |
+100% |
Q4 2024 |
FY 2024 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2025 |
Q2 2025 |
Preferred Stock, Shares Authorized |
1M |
shares |
0% |
Q2 2025 |
Q2 2025 |
Additional Paid in Capital |
13.1K |
USD |
-99.4% |
Q2 2025 |
Q2 2025 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2025 |
Q2 2025 |
Share-based Payment Arrangement, Expense |
6.6K |
USD |
|
Q2 2025 |
Q2 2025 |
Interest Expense |
1.3K |
USD |
|
Q2 2025 |
Q2 2025 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |